ArticleRheumatology advances in practice2026
Combination therapy with TNF inhibitors plus biologics targeting type 2 inflammatory conditions in patients with rheumatoid arthritis: a case series.
Anthony J Ocon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.